HIF1A and malignant glioma: HIF-1α antisense treatment suppressed HIF-1α expression by up to 80% under both normoxic and hypoxic conditions and resulted in significant resistance of U87 malignant glioma cells to the cytotoxicity of cisplatin, etoposide, and vincristine [22].